Predictors for early HBeAg loss during lamivudine therapy in HBeAg-positive chronic hepatitis B patients with acute exacerbation

Hepatology International

Volumn 5, Issue 1, 2011, Pages 586-596

  Peng, Cheng Yuan ^a   Chen, Chih Bin ^a   Lai, Hsueh Chou ^a   Su, Wen Pang ^a   Chuang, Po Heng ^a   Wu, Hong Dar Isaac ^b   Jeng, Long Bin ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Acute exacerbation; Chronic hepatitis B; Decompensation; HBeAg loss; Lamivudine

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; CREATININE; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIGEN DETECTION; ANTIVIRAL THERAPY; ARTICLE; ASCITES; CONTROLLED STUDY; DECOMPENSATED LIVER CIRRHOSIS; DISEASE EXACERBATION; FEMALE; FOLLOW UP; GENE MUTATION; GENOTYPE; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RELAPSE; REMISSION; RETROSPECTIVE STUDY; SEROCONVERSION; SEX DIFFERENCE; TREATMENT DURATION;

EID: 79952628272     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-010-9227-x     Document Type: Article

References (28)

1. G Fattovich 2003 Natural history and prognosis of hepatitis B Semin Liver Dis 23 47 58 10.1055/s-2003-37590 12616450 (Pubitemid 36254662)
2. CM Chu YF Liaw 2007 Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion J Viral Hepat 14 147 152 10.1111/j.1365-2893.2006.00810.x 17305879
3. YF Liaw 2003 Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy J Gastroenterol Hepatol 18 246 252 1:CAS:528:DC%2BD3sXjtlKgtr4%3D 10.1046/j.1440-1746.2003.02976.x 12603523 (Pubitemid 36513152)
4. IS Sheen YF Liaw DI Tai, et al. 1985 Hepatic decompensation associated with hepatitis B e antigen clearance in chronic type B hepatitis Gastroenterology 89 732 735 1:STN:280:DyaL2M3os1WmsQ%3D%3D 4029555 (Pubitemid 15015286)
5. B Rehermann M Nascimbeni 2005 Immunology of hepatitis B virus and hepatitis C virus infection Nat Rev Immunol 5 215 229 1:CAS:528: DC%2BD2MXhslSju7k%3D 10.1038/nri1573 15738952 (Pubitemid 40364823)
6. SL Tsai PJ Chen MY Lai, et al. 1992 Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion J Clin Invest 89 87 96 1:CAS:528:DyaK38Xlslahtg%3D%3D 10.1172/JCI115590 1729285
7. N Shimada K Yamamoto MJ Kuroda, et al. 2003 HBcAg-specific CD8 T cells play an important role in virus suppression, and acute flare-up is associated with the expansion of activated memory T cells J Clin Immunol 23 223 232 1:CAS:528:DC%2BD3sXivVCks7w%3D 10.1023/A:1023366013858 12797544 (Pubitemid 36521216)
8. A Nicoll S Locarnini 1997 Review: present and future directions in the treatment of chronic hepatitis B infection J Gastroenterol Hepatol 12 843 854 1:CAS:528:DyaK1cXhvVylur0%3D 10.1111/j.1440-1746.1997.tb00382.x 9504896 (Pubitemid 28088071)
9. SWC Tsang HLY Chan NWY Leung, et al. 2001 Lamivudine treatment for fulminant hepatic failure due to acute exacerbation of chronic hepatitis B infection Aliment Pharmacol Ther 15 1737 1744 1:CAS:528:DC%2BD3MXosVWqt7s%3D 10.1046/j.1365-2036.2001.01107.x 11683687 (Pubitemid 33001137)
10. HL Chan SW Tsang Y Hui, et al. 2002 The role of lamivudine and predictors of mortality in severe flare-up of chronic hepatitis B with jaundice J Viral Hepat 9 424 428 10.1046/j.1365-2893.2002.00385.x 12431204 (Pubitemid 35373763)
11. RN Chien CH Lin YF Liaw 2003 The effect of lamivudine therapy in hepatic decompensation during acute exacerbation of chronic hepatitis B J Hepatol 38 322 327 1:CAS:528:DC%2BD3sXhtVemtbk%3D 10.1016/S0168-8278(02)00419-1 12586298 (Pubitemid 36286545)
12. MF Yuen E Sablon CK Hui, et al. 2003 Prognostic factors in severe exacerbation of chronic hepatitis B Clin Infect Dis 36 979 984 10.1086/374226 12684909 (Pubitemid 36513281)
13. A Tsubota Y Arase Y Suzuki, et al. 2005 Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B J Gastroenterol Hepatol 20 426 432 1:CAS:528:DC%2BD2MXjtlahtLs%3D 10.1111/j.1440-1746.2004. 03534.x 15740488 (Pubitemid 40469345)
14. CY Dai ML Yu MY Hsieh, et al. 2007 Early response to lamivudine therapy in clinically non-cirrhotic chronic hepatitis B patients with decompensation Liver Int 27 1364 1370 1:CAS:528:DC%2BD1cXkvVGjtQ%3D%3D 10.1111/j.1478-3231. 2007.01565.x 17900250 (Pubitemid 350142250)
15. RN Chien YF Liaw M Atkins 1999 Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B Hepatology 30 770 774 1:CAS:528: DyaK1MXmtVSkt7Y%3D 10.1002/hep.510300313 10462384 (Pubitemid 29409422)
16. RP Perrillo CL Lai YF Liaw, et al. 2002 Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B Hepatology 36 186 194 1:CAS:528:DC%2BD38Xlslyqsr4%3D 10.1053/jhep.2002.34294 12085364 (Pubitemid 34700777)
17. N Akuta A Tsubota F Suzuki, et al. 2003 Long-term prognosis by lamivudine monotherapy for severe acute exacerbation in chronic hepatitis B infection: emergence of YMDD motif mutant and risk of breakthrough hepatitis - an open-cohort study J Hepatol 38 91 97 1:CAS:528:DC%2BD38XptlSqtLs%3D 10.1016/S0168-8278(02)00335-5 12480565 (Pubitemid 36078529)
18. A Tsubota Y Arase F Suzuki, et al. 2004 Severe acute exacerbation of liver disease may reduce or delay emergence of YMDD motif mutants in long-term lamivudine therapy for hepatitis B e antigen-positive chronic hepatitis B J Med Virol 73 7 12 1:CAS:528:DC%2BD2cXjslersLg%3D 10.1002/jmv.20055 15042641 (Pubitemid 38429140)
19. VW Wong GL Wong SW Tsang, et al. 2008 Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B Antivir Ther 13 571 579 18672536 (Pubitemid 352016720)
20. DY Lin IS Sheen CT Chiu, et al. 1993 Ultrasonographic changes of early liver cirrhosis in chronic hepatitis B: a longitudinal study J Clin Ultrasound 21 303 308 1:STN:280:DyaK3s3psVSgtg%3D%3D 10.1002/jcu.1870210502 8514896 (Pubitemid 23150288)
21. MS Dai PF Wu RY Shyu, et al. 2004 Hepatitis B virus reactivation in breast cancer patients undergoing cytotoxic chemotherapy and the role of preemptive lamivudine administration Liver Int 24 540 546 1:CAS:528: DC%2BD2MXmtVaitA%3D%3D 10.1111/j.1478-3231.2004.0964.x 15566502 (Pubitemid 40028604)
22. M Mizokami T Nakano E Orito, et al. 1999 Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns FEBS Lett 450 66 71 1:CAS:528:DyaK1MXivFegsbg%3D 10.1016/S0014-5793(99)00471-8 10350059 (Pubitemid 29206714)
23. TC Tseng CJ Liu CC Wang, et al. 2008 A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients Liver Int 28 1034 1041 1:CAS:528:DC%2BD1cXhtVWqu7zM 10.1111/j.1478-3231.2008.01766.x 18492018 (Pubitemid 352044452)
24. CE Stevens RP Beasley J Tsui, et al. 1975 Vertical transmission of hepatitis B antigen in Taiwan N Engl J Med 292 771 774 1:STN:280: DyaE2M7gtVamsg%3D%3D 10.1056/NEJM197504102921503 1113797
25. HY Hsu MH Chang DS Chen, et al. 1986 Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan J Med Virol 18 301 307 1:STN:280:DyaL283is1aitA%3D%3D 10.1002/jmv.1890180402 2940332
26. YF Liaw CM Chu MJ Huang, et al. 1984 Determinants for hepatitis B e antigen clearance in chronic type B hepatitis Liver 4 301 306 1:STN:280:DyaL2M%2FmtVamsA%3D%3D 6503634
27. CM Chu IS Sheen SM Lin, et al. 1993 Sex difference in chronic hepatitis B virus infection: studies of serum HBeAg and alanine aminotransferase levels in 10, 431 asymptomatic Chinese HBsAg carriers Clin Infect Dis 16 709 713 1:STN:280:DyaK3s3otlGlsg%3D%3D 8507764
28. CM Chu SJ Hung J Lin, et al. 2004 Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels Am J Med 116 829 834 1:CAS:528:DC%2BD2cXkslWltLs%3D 10.1016/j.amjmed.2003.12.040 15178498 (Pubitemid 38721324)